Role of CD20 expression and other pre-treatment risk factors in the development of infusion-related reactions in patients with CLL treated with obinutuzumab.

ABSTRACT:

SUBMITTER: Freeman CL 

PROVIDER: S-EPMC4980557 | biostudies-literature | 2016 Aug

REPOSITORIES: biostudies-literature